Viewing Study NCT00743067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-01-20 @ 11:07 PM
Study NCT ID: NCT00743067
Status: COMPLETED
Last Update Posted: 2017-07-26
First Post: 2008-08-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None XL880 View
None MET inhibitor View
None GSK1363089 View
None Solid Tumors View
None c-Met View